| A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer (NCT06344351) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-04-25 |
| Safety Study of PP-007 in Subjects With Acute Ischemic Stroke (NCT04677777) | Prolong Pharmaceuticals | 2024-04-24 |
| Human Models of Selective Insulin Resistance: Alpelisib, Part I (NCT06354088) | Columbia University | 2024-04-24 |
| Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation (NCT06110572) | Vanderbilt-Ingram Cancer Center | 2024-04-24 |
| A Study of the Effects of Food and Cobicistat on Plixorafenib Pharmacokinetics in Healthy Participants. (NCT06385119) | Fore Biotherapeutics | 2024-04-24 |
| A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer (NCT06114511) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-04-24 |
| Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) (NCT05665361) | National Cancer Institute (NCI) | 2024-04-24 |
| The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers (NCT06432673) | Atrogi AB | 2024-04-24 |
| PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function (NCT06729853) | Shanton Pharma Pte. Ltd. | 2024-04-24 |
| Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer (NCT06249282) | City of Hope Medical Center | 2024-04-24 |
| A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105 (NCT06432647) | LeonaBio | 2024-04-24 |
| The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai Volunteers (NCT06243809) | International Bio service | 2024-04-24 |
| Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project (NCT05989581) | University of Alabama at Birmingham | 2024-04-24 |
| A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027) (NCT06772792) | Merck Sharp & Dohme LLC | 2024-04-23 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies (NCT06351527) | InnoCare Pharma Inc. | 2024-04-23 |
| To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004 (NCT06431399) | Jeil Pharmaceutical Co., Ltd. | 2024-04-23 |
| Safety and Effectiveness of Mesenchymal Stem Cells in Blood Purification for the Treatment of Liver Failure (NCT06904755) | Kebo Zhong | 2024-04-23 |
| Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM (NCT06503107) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-04-23 |
| A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014) (NCT06821334) | Merck Sharp & Dohme LLC | 2024-04-23 |
| A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects (NCT06310746) | Shanghai Henlius Biotech | 2024-04-23 |
| A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy Participants (NCT06363630) | Celgene | 2024-04-23 |
| Comparative Exercise-Induced Hypoalgesia in Upper and Lower Limbs: A Randomized Controlled Trial in Healthy Individuals (NCT06283186) | Centro Universitario La Salle | 2024-04-23 |
| Low Dose Bupivacaine Versus Prilocaine Regarding Hemodynamic Stability and Safety in Geriatrics (NCT06382220) | Fayoum University Hospital | 2024-04-23 |
| A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine (NCT06147622) | Kinnov Therapeutics | 2024-04-23 |
| A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors (NCT06384807) | Biohaven Therapeutics Ltd. | 2024-04-22 |
| A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo (NCT06435936) | SAb Biotherapeutics, Inc. | 2024-04-22 |
| Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances (NCT05110742) | M.D. Anderson Cancer Center | 2024-04-22 |
| A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects (NCT06309043) | Shanghai Henlius Biotech | 2024-04-22 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B (NCT05828745) | Shanghai Zhimeng Biopharma, Inc. | 2024-04-22 |
| An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005 (NCT07442149) | Alumis Inc | 2024-04-22 |
| Psilocybin in Chronic Low Back Pain and Depression (NCT06355414) | Johns Hopkins University | 2024-04-22 |
| A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors (NCT06383507) | Zhejiang University | 2024-04-22 |
| A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer (NCT06385080) | Janssen Research & Development, LLC | 2024-04-22 |
| SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS (NCT06325748) | Senti Biosciences | 2024-04-22 |
| Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) (NCT06551233) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-04-22 |
| Telmisartan in Prostate Cancer (NCT06168487) | Tyler J Curiel | 2024-04-22 |
| Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets (NCT06484673) | Humanis Saglık Anonim Sirketi | 2024-04-21 |
| A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults (NCT06243835) | Lohocla Research Corporation | 2024-04-21 |
| CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL (NCT06064903) | Bambino Gesù Hospital and Research Institute | 2024-04-21 |
| KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts (NCT06469450) | Mikko Niemi | 2024-04-20 |
| The Effectiveness of Using a Single Post-operative Intramuscular Dexamethasone Injection on Patients with Surgical Extraction of Lower Third Molar (NCT06809855) | Yassir R. Al-khannaq | 2024-04-20 |
| Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B (NCT06618079) | Huons Co., Ltd. | 2024-04-20 |
| Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies (NCT07584889) | Shenzhen University General Hospital | 2024-04-20 |
| A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT06349811) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-04-19 |
| RT-310 Dose Escalation BPH Study (NCT06136819) | Resurge Therapeutics Inc. | 2024-04-19 |
| Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug (NCT06391736) | GeneCradle Inc | 2024-04-19 |
| Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers (NCT06167707) | scPharmaceuticals, Inc. | 2024-04-19 |
| A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated (NCT06310005) | Boehringer Ingelheim | 2024-04-19 |
| A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors (NCT06730659) | Tianjin Medical University Cancer Institute and Hospital | 2024-04-19 |
| Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT06177067) | St. Jude Children's Research Hospital | 2024-04-19 |
| Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma (NCT05990751) | University College, London | 2024-04-19 |
| Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors (NCT06349837) | Sichuan University | 2024-04-18 |
| A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major (NCT06291961) | CorrectSequence Therapeutics Co., Ltd | 2024-04-18 |
| Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) (NCT06285422) | Sana Biotechnology | 2024-04-18 |
| Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum (NCT05325099) | National Taiwan University Hospital | 2024-04-18 |
| A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003) (NCT06294912) | Merck Sharp & Dohme LLC | 2024-04-18 |
| Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors (NCT06293651) | Dong-A ST Co., Ltd. | 2024-04-18 |
| Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer (NCT05777603) | National Cancer Institute (NCI) | 2024-04-18 |
| Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis (NCT06261528) | University of Texas Southwestern Medical Center | 2024-04-18 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets (NCT06534320) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2024-04-18 |
| Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study (NCT06345560) | Chulalongkorn University | 2024-04-18 |
| Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC (NCT06217757) | Sichuan University | 2024-04-18 |
| Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy (NCT06164587) | Inflammasome Therapeutics | 2024-04-18 |
| A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia (NCT05748197) | Memorial Sloan Kettering Cancer Center | 2024-04-18 |
| A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers (NCT06194877) | MapKure, LLC | 2024-04-18 |
| A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults (NCT06382311) | GlaxoSmithKline | 2024-04-18 |
| A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants (NCT06360211) | Bayer | 2024-04-17 |
| Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function (NCT03896750) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-04-17 |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer (NCT06030622) | State University of New York - Downstate Medical Center | 2024-04-17 |
| A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies (NCT07011186) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-04-17 |
| A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs (NCT06228326) | Krystal Biotech, Inc. | 2024-04-17 |
| Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate. (NCT06408337) | Elisa María Cubiles Montero de Espinosa | 2024-04-17 |
| Washed Microbiota Transplantation for Tourette's Syndrome (NCT03764748) | The Second Hospital of Nanjing Medical University | 2024-04-17 |
| A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors (NCT06394414) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2024-04-17 |
| Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma (NCT06123468) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2024-04-17 |
| A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery (NCT05316688) | University of Washington | 2024-04-17 |
| Pemigatinib + Afatinib in Advanced Refractory Solid Tumors (NCT06302621) | Massachusetts General Hospital | 2024-04-17 |
| A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants (NCT06345755) | Vertex Pharmaceuticals Incorporated | 2024-04-17 |
| A Study to Investigate the Effect of Food on the Bioavailability of a Capsid Inhibitor (CAI) in Male and Female Healthy Participants (NCT06368986) | ViiV Healthcare | 2024-04-17 |
| Comparative PK/PD of Single-Dose THDB0206 at Different Injection Sites (NCT07257627) | Tonghua Dongbao Pharmaceutical Co.,Ltd | 2024-04-17 |
| TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma (NCT06323525) | Chinese PLA General Hospital | 2024-04-17 |
| Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease (NCT06325709) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-04-17 |
| A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease (NCT06114745) | Atridia Pty Ltd. | 2024-04-17 |
| P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies (NCT06014762) | Poseida Therapeutics, Inc. | 2024-04-16 |
| A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants (NCT06357520) | AstraZeneca | 2024-04-16 |
| A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors (NCT05949632) | Incyte Corporation | 2024-04-16 |
| A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients (NCT06453668) | ITB-Med LLC | 2024-04-16 |
| Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC) (NCT06155500) | Novartis Pharmaceuticals | 2024-04-16 |
| Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD (NCT06345404) | Corvus Pharmaceuticals, Inc. | 2024-04-16 |
| A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers (NCT06462326) | Zai Lab (Hong Kong), Ltd. | 2024-04-16 |
| A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors (NCT06364696) | Astellas Pharma Inc | 2024-04-16 |
| Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS (NCT06392126) | n-Lorem Foundation | 2024-04-16 |
| Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers (NCT06334211) | Foresee Pharmaceuticals Co., Ltd. | 2024-04-16 |
| A Study to Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted (NCT05983874) | International AIDS Vaccine Initiative | 2024-04-16 |
| Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients (NCT06808295) | Research Institute of Ophthalmology, Egypt | 2024-04-16 |
| A Study of MHB039A for Advanced Solid Tumor (NCT06345482) | Minghui Pharmaceutical (Hangzhou) Ltd | 2024-04-16 |
| A Study of LY3841136 in Japanese Participants With Obesity or Overweight (NCT06297616) | Eli Lilly and Company | 2024-04-15 |
| Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy (NCT05973734) | Stanford University | 2024-04-15 |
| Evaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy Volunteers (NCT06402136) | Traws Pharma, Inc. | 2024-04-15 |
| LYell SYndrome MEsenchymal Stromal Cells Treatment (NCT04711200) | Assistance Publique - Hôpitaux de Paris | 2024-04-15 |